Standout Papers
- Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial (2004)
- A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database (2007)
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402 (2012)
- Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial (2014)
- Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients (2009)
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial (2013)
- Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity (2008)
- Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial (2013)
- Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402 (2006)
- American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of Stereotactic Body Radiation Therapy (2010)
- Hippocampal Dosimetry Predicts Neurocognitive Function Impairment After Fractionated Stereotactic Radiotherapy for Benign or Low-Grade Adult Brain Tumors (2013)
- NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (2022)
Immediate Impact
26 by Nobel laureates 26 from Science/Nature 123 standout
Citing Papers
De novo design of allosterically switchable protein assemblies
2024 StandoutNatureNobel
Glioblastoma and Other Primary Brain Malignancies in Adults
2023 Standout
Works of Minesh P. Mehta being referenced
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
2022 Standout
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
2012 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Minesh P. Mehta | 25249 | 20333 | 10314 | 1.1k | 44.1k | |
| Walter J. Curran | 19192 | 10470 | 10223 | 661 | 36.0k | |
| Jürgen Debus | 19292 | 6003 | 12013 | 1.3k | 42.3k | |
| Jay S. Loeffler | 11562 | 11046 | 5168 | 364 | 26.3k | |
| James E. Herndon | 14922 | 11233 | 13208 | 477 | 36.7k | |
| Roger Stupp | 13661 | 30511 | 9311 | 373 | 48.5k | |
| Patrick Y. Wen | 11228 | 23253 | 9683 | 775 | 41.8k | |
| Martin J. van den Bent | 14555 | 34321 | 7911 | 573 | 49.5k | |
| Paul D. Brown | 10872 | 10731 | 5589 | 439 | 20.3k | |
| Elizabeth A. Eisenhauer | 12565 | 12331 | 15013 | 205 | 41.1k | |
| Kenneth R. Hess | 14542 | 8378 | 15103 | 506 | 40.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...